InvestorsHub Logo

DewDiligence

05/09/18 2:42 PM

#51 RE: DewDiligence #50

GLMD 1Q18 results—cash=$21.4M (counting $5.9M raised in April PP with BVF):

https://finance.yahoo.com/news/galmed-pharmaceuticals-provides-business-reports-110000240.html

The phase-2b ARREST study in NASH is still expected to read out in Jun 2018.